However, studies have shown MYPT to correlate significantly with drug resistance and poor prognosis in human carcinomas [103,104], thus postulating a plausible role of PPP1R12B in drug resistance and poor prognosis in OSCC or HNSCC. Here, PPP1R12B is linked to head and neck squamous cell carcinoma.